financetom
Business
financetom
/
Business
/
Exxon Mobil Sees Earnings Boost From Oil Prices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exxon Mobil Sees Earnings Boost From Oil Prices
Oct 7, 2025 4:52 AM

Exxon Mobil Corporation ( XOM ) shares are trading higher premarket on Tuesday. On Monday, the oil giant stated that it anticipates changes in oil prices to impact its Upstream results by ($100) million to $300 million in the third quarter compared to the second quarter.

Also, changes in gas prices are expected to impact its Upstream results by ($200) million to $200 million.

Also, Exxon Mobil ( XOM ) projects that variations in industry margins will positively impact Energy Products earnings by $300 million to $700 million.

Also Read: ExxonMobil Remains The Go-To Safety Trade In Volatile Energy Market: Analysts

On the other hand, the company expects changes in industry margins to impact Chemical Products earnings by $100 million – $300 million and Specialty Products earnings by ($100) million – $100 million in the third quarter.

Moreover, changes in timing effects are expected to have an impact of ($400) million to $0.0 billion in Upstream earnings and ($200 million to $200 million on Energy Products earnings.

Additionally, scheduled maintenance is expected to impact Upstream, Chemical Products, and Specialty Products results by ($100 million) – $100 million each, while Energy Products may see an effect of $0.0 billion – $200 million.

According to Benzinga Pro, analysts estimate Exxon Mobil ( XOM ) to report third-quarter adjusted earnings per share of $1.79 and revenues of $87.18 billion.

Last month, the company reportedly entered into a preliminary, non-binding arrangement with Russia’s Rosneft to explore avenues for recovering billions lost after its withdrawal from Russian operations in 2022.

The company plans to release third-quarter results on October 31.

Investors can gain exposure to XOM via Global X Funds Global X PureCap MSCI Energy ETF and Vanguard Energy ETF .

Price Action: XOM shares were trading higher by 0.52% to $114.79 premarket at last check Tuesday.

Read Next:

Broadcom’s Big AI Move In Japan Could Slash Data Center Power Use By Half

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Abits Group Stock Falling Monday?
Why Is Abits Group Stock Falling Monday?
Mar 11, 2026
Abits Group Inc. ( ABTS ) stock fell Monday after the company said it had entered into definitive agreements with institutional investors for a registered direct offering expected to raise approximately $2.1 million. The company agreed to sell 792,452 Ordinary Shares and pre-funded warrants at $2.65 per share. Each pre-funded warrant was priced at $2.64999, reflecting the public offering price...
GSK, Bora Pharmaceuticals Extend Five-Year Manufacturing Alliance
GSK, Bora Pharmaceuticals Extend Five-Year Manufacturing Alliance
Mar 11, 2026
01:50 PM EST, 02/23/2026 (MT Newswires) -- GSK (GSK) has renewed a five-year manufacturing pact with Bora Pharmaceuticals, the latter said Monday. The broadened collaboration grants the British drugmaker access to several facilities across the production network, including a recently added oral solid dose plant in Minnesota, Bora said. Price: 59.37, Change: -0.16, Percent Change: -0.26 ...
General Electric Lands Air Force Deal
General Electric Lands Air Force Deal
Mar 11, 2026
General Electric ( GE ) Co. shares are down Monday as the company recently announced a joint U.S. Air Force contract with Kratos Defense & Security Solutions, Inc. valued at $12.4 million. The contract entails desiging a next-generation engine for small Collaborative Combat Aircraft (CCA). How GE’s New Engine Redefines Affordability Announced on Feb. 23, 2026, this initiative focuses on...
Update: Novo Nordisk Shares Fall After Obesity Drug CagriSema Fails to Meet Primary Trial Endpoint
Update: Novo Nordisk Shares Fall After Obesity Drug CagriSema Fails to Meet Primary Trial Endpoint
Mar 11, 2026
01:53 PM EST, 02/23/2026 (MT Newswires) -- (Updates with Novo Nordisk's ( NVO ) latest stock price movement in the headline and the first paragraph, and Eli Lilly's ( LLY ) latest share movement in the last paragraph.) Novo Nordisk ( NVO ) shares were down nearly 16% in recent Monday trading after the company said its weight-loss treatment CagriSema...
Copyright 2023-2026 - www.financetom.com All Rights Reserved